Četvrtak, 19.oktobar /Thursday, October 19 Palisad 300 Prof. Dr. Jovan Mićić. Palisad 200 General Krsta Smiljanić
|
|
|
- Nathaniel Kelly
- 6 years ago
- Views:
Transcription
1 Tabelarni prikaz naučnog program XXI kongresa Udruženja kardiologa Srbije () oktobar, 2017, Zlatibor Program-at-glance of the XXI Congress of the Cardiology society of Serbia (CSS), October 19-22, 2017, Zlatibor Mona 400 Srećko Nedeljković Interventna kardiologija u Srbiji/ Interventional cardiology in Serbia Četvrtak, 19.oktobar /Thursday, October 19 Palisad 300 Jovan Mićić UKJS na kongresu kardiologa/ CSS at the Congress Palisad 200 General Krsta Smiljanić Primena trombolitičke terapije na granicama preporuka/ The use of thrombolytic therapy at the limits of recommendations Pauza/Break Najbolje od ESC 2017 Kompleksne intervencije u jedinici intenzivne i ESC/ The nege/ Complex best of ESC 2017 procedures in ICU IKVBV i KCS Perioperativna primena DAPT u kardiohirurgiji/ Peri-operative management of patients undergoing cardiac surgery: the use of DAPT Palisad 100 Dimitrije Tucović Dijagnostičke procedure u aritmologiji/ Diagnostic procedures in arrhythmology RG za EF Mala škola kliničke kardiologije/ Clinical cardiology in brief Palisad 80 Milutin Uskoković 27 godina privatne lekarske prakse Srbije- iskustva iz prakse/ The 27 years of private medical practice in Serbia day to day experience RG za privatnu praksu Kardio-onkologija/ Cardio-oncology kardiologa, hematologa i onkologa Palisad 50 Ljubomir Stojanović
2 18.30 Pauza/Break Svečano otvaranje/opening ceremony Vreme Mona 400 Srećko Nedeljković Personalizovana KV prevencija/ Personalized CVD prevention HISPA Palisad 300 Jovan Mićić STEMI ekvivalent/ STEMI equivalent Petak, 20.oktobar/Friday, October 20 Palisad 200 General Krsta Smiljanić Atrijalna fibrilacija 1: Paroksizmalna AF Pro et contra/ A- fib 1: Parox. A-fib Pro et contra Palisad 100 Dimitrije Tucović 3D/4D eho kroz prikaze slučajeva/ 3D/4D echo: case IKVBV i VMA RG za EF Pauza/Break Sportska Kako kardiološki Atrijalna kardiologija/ zbrinuti fibrilacija 2:, ESC, Med Sports cardiology kardiohiruškog Perzistentna AF/ odeljenja AN Palisad 80 Milutin Uskoković Život pacijenata posle revaskualrizacije miokarda/ Life of a patient after cardiac revascularization IKVBV i Sokobanjske Sesija mladih interventnih kardiologa/ Palisad 50 Ljubomir Stojanović Bazične nauke u kardiologiji/ Basic science research and cardiology AKS/
3 10.15 bolesnika?/ Management of patients undergoing cardiac surgery: The best approach? Atrial fibrillation 2: Persistent A-fib RG za EF Mađarske, Odbor za KV patologiju SANU, ANURS/ Life of a patient after cardiac revascularization Forum mladih kardiologa ACS Superzajednička sesija Srbije u malom PharmaSwiss Promocija knjige Praktična TEE Hemofarm Generalni sponzor Astra Zeneca Medtronic PharmaSwiss Boehringer Medtronic 40 godina PCI I deo/ 40 years of Servier Actavis PCI Part one RG za intervetnu kardiologiju + Medtronic, Terumo, Asahi Pfizer Miokardna Sinergija u Savremeni Pristup Heart team za AKS/
4 15.45 revaskularizacija /Myocardial revascularization Sinergiji/ Synergy in Synergy Zajednička sesija i Sinergije trendovi u prevenciji ateroskleroze/ New trends in atherosclerosis prevention RG za aterosklerozu bolesnicima sa arterijskim I venskim trombozama Radionica sa prikazima slučajeva/ Arterial and venous thrombosis: Workshop and case Pauza/Break KV prevencija/ CVD prevention Atrijalna fibrilacija Akutni infarkt miokarda sa izazovi u elevacijom ST svakodenvnj segmenta/ Acute 18.00, Fondacije praksi/ A-fib myocardial Srbije za vaše challenges in infarction with srce i ESC everyday ST-segment practice elevation Zajednička sesija i SAFA RG za AKS Akutna srčana slabost: Da li smo otišli dalje od početka?/ Acute heart failure: Did we go further from the start? Pauza/Break Dijabetes i KV Expert Eho Mogućnosti bolesti: Od radionica: interventne odbojnosti do Hipertrofićna kardiologije/ privlačnosti/ miokardiopatija/ Possibilities of Diabetes and Expert Echo interventional CVD: From antagonism to attraction workshop: Hypertrophic Cardiomyopathy cardiology Odbor za KV Zajednička sesija IKVBV i IKVB Dedinje Dijastolni stres test i srčana slabost/ Diastolic stress test and heart failure Instututa Niška Banja, KCS, i IKVBV Heart team in ACS kardiologa i kardiohirurga Koronarna ili ishemijska bolest srca, razumemo li razlike?/ CAD or ischemic heart disease: do we understand the differences? RG za koronarnu patofiz., mikrocir., funkciju miokarda Laboratorija Istine i zablude u 2017/ Blood work the truth and misleads in 2017 Neinvazivna kardiologija/ Non-invasive cardiology Koronarna bolest i invazivna kardiologa/ Abstrcts Coronary artery disease and invasive cardiology Sastanak RG za pejsing i resinhronizaciju
5 20.00 patologiju SANU, UDS i Mona 400 Srećko Nedeljković Infektivni endokarditis kroz prikaze slučaja/ Infective endocarditis: case Subota, 21.oktobar/Saturday, October 21 Palisad 300 Jovan Mićić Najbolje od ACC 2017/ The best of ACC 2017 Ogranak ACC Srbije i R. Srpska Palisad 200 General Krsta Smiljanić Put od akutne plućne embolije do hronične tromboembolijske bolesti pluća/ From acute PTE to chronic PTE disease Palisad 100 Dimitrije Tucović Hipertenzija I/ Hypertension 1 I Udruženja za hipertenziju Srbije Palisad 80 Milutin Uskoković Dečja kardiologija/ Pediatric cardiology Palisad 50 Ljubomir Stojanović Kardiohirurgija/ Cardiac surgery Pauza/Break Više od stres eha../more of stress echo ESC STEMI preporuke/esc guidelines on STEMI Urođene srčane mane: Modaliteti lečenja/ Congenital heart diseases: Management Rehabilitacija KV bolesnika/ Rehabilitation of CV patients RG za imidžing Krka Medtronic Roche Diagnostics Actavis Generalni Heart team odgovarajuća odluka o revaskularizaciji/ Heart team choice of the best revascularization method Srčana insuficijencija, Valvularne mane/ HF and VHD
6 12.15 sponsor Astra Zeneca Amikus Bayer Boerhinger 40 godina PCI II deo/40 years of PCI Part two Servier Pfizer/Medtronic Sanofi Mylan ADOC Vavularne bolesti srca u XXI veku: Gde smo i kuda idemo?/ VHD in XXI century: Where are we now and where do we go from here? RG za valvularne mane Srčana insuficijencija 2017: Budućnost je već počela/ Heart failure 2017: The future is now i Udruženja za srčanu slabost Srbije Pro et contra u lečenju plućne embolije/ Pro et contra in PTE treatment RG za interventnu kardiologiju + Boston Scientific, Biotronik, Abbot Vascular STEMI i DAPT/ STEMI and DAPT, UKCG, UKRS i prijatelja Savremene mogućnosti PCI/ New PCI methods RG za interventnu kardiologiju Poremećaji ritma i sprovođenja/ Arrhythmias and conduction abnormalities Pauza/Break ESC preporuke Transplantacija Diferencijalna Hipertenzija II/ Kardio-nefrologija/
7 17.30 za valvularne mane kroz prikaze slučajeva/esc guidelines on VHD: case srca i potporni uređaji/heart transplantation and mechanical circulatory support dijagnoistika srčanih aritmija/ Differential diagnostics of cardiac arrhythmias Hypertension 2 i Udruženja za hipertenziju Srbije Pauza/Break AF: Stari poremećaj ritma Uvek u fokusu: Arterijska Kontrastni eho/ Contrast echo Kateterska ablacija sa novim hipertenzija/ ventrikularnih dilemama/a-fib: Always in a focus: aritmija. Kome? Old arrhythmia hypertension Kada? Kako?/ with new dilemmas Cath. ablation of ventr. arrhythmias: To whom? When? How? Cardio-nephrology Preporuke rehabilitacije kardioloških pacijenata/ Guidelines on rehabilitation of cardiac patients RG za rehab. KV prevencija, hipertenzija, sportska kardiologija/ CVD prevention, HTN and sports cardiology Mona 400 Srećko Nedeljković Infektivni endokarditis/ Infective endocarditis RG za EF Nedelja, 22.oktobar/Sunday, October 22 Palisad 300 Jovan Mićić AKS: primeri iz prakse/ ACS: every day cases from clinical practice Palisad 200 General Krsta Smiljanić Kardioonkologija kroz prikaze slučaja/ Cardiooncology: case Palisad 100 Dimitrije Tucović Genetski aritmjski sindromi kroz prikaze slučajeva i novi koncepti/ The new concept Palisad 80 Milutin Uskoković RG sestre i tehničari Palisad 50 Ljubomir Stojanović
8 10.15 KCS, VMA i kardiohirurga of inherited cardiac arrhythmia: case RG za aritmije Pauza/Break Periopertivni izazovi antitrombocitne i antikoagulantne terapije/ Peri-operative challenges: the use of antithrombotic and anticoagulation therapy Bolesti perikarda/ Pericardial disease Kontrola duvana/ Tobacco control Zajednička sesija I Kancelariju za borbu protiv pušenja Prikazi slučajeva urođene srčane mane/ Congenital heart disease: case RG za imidžing RG sestre i tehničari Zatvaranje kongresa /Closing ceremony
XXI Congress of the Cardiology Society of Serbia (CSS) Preliminary Programme Zlatibor, October, 2017
XXI Congress of the Cardiology Society of Serbia () Preliminary Programme Zlatibor, 19-22 October, 15.00 Interventional Cardiology in Serbia 15.15 15.30 15.45 16.00 16.15 at the Congress Thursday, October
List of Workshops Workshop Title
List of Workshops 2017 Year 2017 A CANADIAN HEART RHYTHM SOCIETY WORKSHOP: MANAGEMENT OF VENTRICULAR TACHYCARDIA 2017 CANADIAN SOCIETY OF CARDIOVASCULAR NUCLEAR AND CT IMAGING: CORONARY ATHEROSCLEROSIS
ARRHYTHMIAS AND DEVICE THERAPY
Topic List A BASICS 1 History of Cardiology 2 Clinical Skills 2.1 History Taking 2.2 Physical Examination 2.3 Electrocardiography 2.99 Clinical Skills - Other B IMAGING 3 Imaging 3.1 Echocardiography 3.2
CardioS Petak / Friday,
Petak / Friday, 08. 04. 2016. 30 PETAK / FRIDAY, 20. 04. 2018. SALA SRCE / ROOM HEART SALA AORTA / ROOM AORTA 08.00 Sesija 1 / Session 1 SIMPOZIJUM. Bolje sprečiti nego lečiti. Prevencija srčane slabosti
When Should I Order a Stress Test or an Echocardiogram
When Should I Order a Stress Test or an Echocardiogram Updates in Cardiology 2015 March 7, 2015 Donald L. Lappé, MD, FAHA, FACC Chairman, Cardiovascular Department Medical Director, Intermountain Cardiovascular
Early Career Investigator Awards. 84 Lipid and Lipoprotein Metabolism: Clinical Lifestyle & Behavioral Medicine
AHA Scientific Sessions Awards and Travel Grants Available by Abstract Category and Award applicants must have submitted an abstract to a category listed under that award and be a member of award s the
New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.
New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. Measure Steward Measure Name Measure Description Rationale for Adding
The Universal Definition of Myocardial Infarction 3 rd revision, 2012
The Universal Definition of Myocardial Infarction 3 rd revision, 2012 Joseph S. Alpert, MD Professor of Medicine, University of Arizona College of Medicine, Tucson, AZ; Editor-in-Chief, American Journal
Schedule Overview Wednesday 5th December 2018
POCKET PROGRAMME Schedule Overview Wednesday 5th Networking Speaker Preview Registration Satellite Symposia Exhibition & E-Posters Date 15:00-18:00 15:00-18:00 Tuesday 4 12:30-13:30 Welcome Reception 10:45-18:00
ASE 2011 Appropriate Use Criteria for Echocardiography
ASE 2011 Appropriate Use Criteria for Echocardiography Table 1. TTE for General Evaluation of Cardiac Structure and Function 1 2 Suspected Cardiac Etiology General With TTE Symptoms or conditions potentially
What s New in the AF Guidelines
Impact on New AF Guidelines on Heart Failure Management Gothenburg - May 22 nd 2011 Europace (2010) 12, 1360-420 http://europace.oxfordjournals.org JACC (2011) 57, 223-42 http://www.cardiosource.org What
Clinical and Economic Value of Rivaroxaban in Coronary Artery Disease
CHRISTOPHER B. GRANGER, MD Professor of Medicine Division of Cardiology, Department of Medicine; Director, Cardiac Care Unit Duke University Medical Center, Durham, NC Clinical and Economic Value of Rivaroxaban
The life after myocardial infarction: a long quiet river?
The life after myocardial infarction: a long quiet river? Cardiac rehabilitation: for whom and how? Dr. Barnabas GELLEN MD, PhD, FESC Poitiers JESFC 2018 - Paris Conflicts of interest Speaker honoraria
Preliminary Programme
Preliminary Programme The scientific programme comprises various styles of presentations and sessions, each offering a unique opportunity to amass new and important scientific information. Optimal management
Challanges in evaluation of coronary artery disease in patients with diabetes
Challanges in evaluation of coronary artery disease in patients with diabetes Branko Beleslin, MD, PhD, FESC, FACC Cardiology Clinic, Clinical centre of Serbia Medical faculty, University of Belgrade Scope
7. Echocardiography Appropriate Use Criteria (by Indication)
Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions
NHAM ASM Day 1, Friday (13 th April 2018) Venue: Hilton Kuala Lumpur & Le Meridien Kuala Lumpur
Day 1, Friday (13 th April 2018) Venue: Hilton Kuala Lumpur & Le Meridien Kuala Lumpur NHAM ASM 2018 Time Ballroom C 0700-0800 Interactive Case discussion 2 Arrhythmia Chairpersons: 1. 2. 0800-1030 0800-0850
Quality Payment Program: Cardiology Specialty Measure Set
Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for
Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)
Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for Artery, Atrial Fibrillation, Hypertension
Common Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
National registries for quality improvement and research
Swedish experiences: National registries for quality improvement and research Stefan James Professor of Cardiology Uppsala Clinical Research Centre Uppsala University Uppsala, Sweden Evidence based health
V Baltic Heart Failure Meeting and Arrhythmias Baltica October Bellevue Park Hotel Riga, 1 Slokas Street, Riga, Latvia Scientific Programme
October 20 V Baltic Heart Failure Meeting and Arrhythmias Baltica 20 21 October Bellevue Park Hotel Riga, 1 Slokas Street, Riga, Latvia Scientific Programme 09:00 12:00 Registration 12:00 12:20 OPENING
Subsequent management and therapies
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Subsequent management and therapies Marco Valgimigli, MD, PhD University of Ferrara ITALY
Update in Cardio-Oncology
Update in Cardio-Oncology Dr. Alexander Lyon BHF Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK President of British Cardio-Oncology Society
STEMI Linee guida ESC Maddalena Lettino, Italy
STEMI Linee guida ESC 2017 Maddalena Lettino, Italy Disclosure Speaker fee: Aspen, Astra Zeneca, BMS, Boehringer, Eli Lilly, DaichiiSankio, Bayer, Pfizer, Sanofi Advisory board member: Astra Zeneca, Eli
ST3 ST4 ST5 ST6 ST7 ALS
2010 Cardiology (amendments 2016) ARCP Decision Aid The table that follows includes a column for each training year which documents the targets that have to be achieved for a ARCP outcome at the end of
8 th ANNUAL CLINICAL CARDIOLOGY COURSE Nashville, TN
8 th ANNUAL CLINICAL CARDIOLOGY COURSE Nashville, TN Mark your Calendar for July 26-29, 2018 to Attend the Only Available Comprehensive Review of Clinical Cardiology Practice designed for Nurse Practitioners
Coagulation and ischaemic stroke
ESC Council on Stroke ESC Heart & Brain Workshop Prague, January 2018 Coagulation and ischaemic stroke Wolfram Doehner, PD, PhD Center for Stroke Research Berlin & Department of Cardiology, Campus Virchow
Practice-Level Executive Summary Report
PINNACLE Registry Metrics 0003, Test Practice_NextGen [Rolling: 1st April 2015 to 31st March 2016 ] Generated on 5/11/2016 11:37:35 AM American College of Cardiology Foundation National Cardiovascular
Update Guidelines in STEMI Management: Focus on Logistic and System Approach to Reperfusion Therapy
March 14 th, 2018 The First Asia Forum in Emergency Medicine BNH Hospital, Bangkok, Thailand Update Guidelines in STEMI Management: Focus on Logistic and System Approach to Reperfusion Therapy Wacin Buddhari,
Antithrombotic therapy in CAD patients with concomitant NAFV: why and for whom?
Antithrombotic therapy in CAD patients with concomitant NAFV: why and for whom? Institut de Cardiologie de la Pitié-Salpêtrière jean-philippe.collet@psl.aphp.fr www.action-coeur.org Patients (%) Patients
A.K. Gitt, F. Towae, C. Juenger, A. Papp, R. Zahn, U. Zeymer, J. Senges For the STAR-Study-Group Herzzentrum Ludwigshafen, Germany
Impact of Interventional Versus Conservative Approach on 5-Year-Mortality of Patients With Stable Angina and Documented Coronary Artery Disease in Clinical Practice: Results of the STAR-Registry A.K. Gitt,
Atrial Fibrillaiton and Heart Failure: Anticoagulation therapy in all cases?
Atrial Fibrillaiton and Heart Failure: Anticoagulation therapy in all cases? Nicolas Lellouche Fédération de Cardiologie Hôpital Henri Mondor Créteil Disclosure Statement of Financial Interest I currently
Consensus Core Set: Cardiovascular Measures Version 1.0
Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized
UPDATES FROM THE 2018 ANTIPLATELET GUIDELINES
UPDATES FROM THE 2018 ANTIPLATELET GUIDELINES Claudia Bucci BScPhm, PharmD Clinical Coordinator, Cardiovascular Diseases Sunnybrook Health Sciences Centre 21st Annual Contemporary Therapeutic Issues in
Stable Angina: Indication for revascularization and best medical therapy
Stable Angina: Indication for revascularization and best medical therapy Cardiology Basics and Updated Guideline 2018 Chang-Hwan Yoon, MD/PhD Cardiovascular Center, Department of Internal Medicine Bundang
Debate PRO. Dronedarone is an important drug in the management of paroxysmal atrial fibrillation. John Camm
ESC ICM - Internationales Congress Center München 2012 Atrial Fibrillation Controversies in Medical Treatment Debate Dronedarone is an important drug in the management of paroxysmal atrial fibrillation
Abstract. Key words: atrial fibrillation; cerebrovascular disorders; risk assessment; therapeutic occlusion; heart atria.
Page 378 VOJNOSANITETSKI PREGLED Vojnosanit Pregl 2017; 74(4): 378 385. CASE REPORT UDC: 616.12-008.313-06::616.831-005.1-084 DOI: 10.2298/VSP160205202N Left atrial appendage closure with Watchman device
Quality Payment Program: Cardiology Specialty Measure Set
Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor
Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name
Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.
Rotation: Echocardiography: Transthoracic Echocardiography (TTE)
Rotation: Echocardiography: Transthoracic Echocardiography (TTE) Rotation Format and Responsibilities: Fellows rotate in the echocardiography laboratory in each clinical year. Rotations during the first
MILESTONES FOR EACH LEVEL OF TRAINING
MILESTONES FOR EACH LEVEL OF TRAINING MILESTONES: Acute Coronary Syndromes (ACS) Know the epidemiology, causes, pathophysiology, and natural history of ACS, including the roles of plaque rupture or erosion
Joo-Yong Hahn, MD/PhD
Sungkyunkwan University School of Medicine Joo-Yong Hahn, MD/PhD Heart Vascular Stork Institute, Samsung Medical Center Sungkyunkwan University School of Medicine Grant support Korean Society of Interventional
ANTIPAF Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial
European Society of Cardiology Hotline Stockholm - Zone K 31 st August 2010 Placebo ARB Kumagai K, et al. JACC 2003 Discussant ANTIPAF Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial
Detailed Order Request Checklists for Cardiology
Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018
ANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS
ANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS PHM119B September 2016 Anuj Pathak Project Analyst ISBN: 1-62296-345-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA
ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy
ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy Task force on the management of CVD during pregnancy of the ESC Chair: Vera Regitz-Zagrosek, Charite, Berlin None DECLARATION
Chapter 4: Cardiovascular Disease in Patients with CKD
Chapter 4: Cardiovascular Disease in Patients with CKD The prevalence of cardiovascular disease (CVD) was 65.8% among patients aged 66 and older who had chronic kidney disease (CKD), compared to 31.9%
Diabetes and the Heart
Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital
ESC Congress Munich 2018
ESC Congress Munich 2018 25-29 August Where the world of cardiology comes together Topic List European Society of Cardiology - Topic List 2018 1 Topic List Topic A Basics 3 Topic B Imaging 3 Topic C Arrhythmias
Westin Fort Lauderdale 400 Corporate Drive Fort Lauderdale, Florida 33334
8030 Peters Road, D105 Plantation, Florida 33324 (954) 723-0057 Phone (954) 723-0353 Fax email: info@naceonline.com Westin Fort Lauderdale 400 Corporate Drive Fort Lauderdale, Florida 33334 Program Chair
OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.
OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To review the use of antiplatelet agents and oral
Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set
Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer
Timothy Malins, MD, FACC Governor, New York Chapter, American College of Cardiology President, New York Cardiological Society
New York Cardiovascular Symposium December 8-10, 2017 New York Hilton Midtown Thursday, December 7 2:30 p.m. - Registration Rhinelander (2 nd Floor) 6:30 p.m Friday, December 8 6:00 a.m. Registration Rhinelander
Program Schedule Cardiology Update: The Heart of the Matter 2019
Program Schedule Cardiology Update: The Heart of the Matter 2019 Thursday, August 1, 2019 12:50 p.m. Registration and Exhibits 1:50 p.m. Welcome Announcements SESSION 1 2:00 p.m. Long QT Syndrome and Exercise:
Additional Contributor: Glenn Levine (USA).
2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the Management
The Strategic Reperfusion Early After STEMI study Implications for clinical practice
The Strategic Reperfusion Early After STEMI study Implications for clinical practice Robert C. Welsh, MD, FRCPC Associate Professor of Medicine Director, Adult Cardiac Catheterization and Interventional
ACS Management in Low-Resource Settings. ARMANDO GARCIA-CASTILLO MD FACC Director Cardiolink Clin Trials Governor Elected ACC Chapter MEXICO
ACS Management in Low-Resource Settings ARMANDO GARCIA-CASTILLO MD FACC Director Cardiolink Clin Trials Governor Elected ACC Chapter MEXICO DISCLOSURE ( last 12 months) Categories of potential conflict
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National
Cardiovascular Medicine at Reading Hospital: Update May 2018
Cardiovascular Medicine at Reading Hospital: Update May 2018 Eric Elgin, MD, FSCAI, FACC Cardiology Section Chief Department of Medicine Reading Hospital Tower Health System Nothing to disclose Disclosures
Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό
Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling
European Society of Cardiology ESC CONGRESS 2019 TOPICS FOR ABSTRACT SUBMISSION
European Society of Cardiology ESC CONGRESS 2019 TOPICS FOR ABSTRACT SUBMISSION Topics At the time of abstract submission, the submitter must select one single topic to index the abstract. It is important
SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI?
SHOULD A REGIONAL STEMI CENTRE ONLY OFFER PRIMARY PCI? Kurt Huber, MD 3 Department of Internal Medicine, Cardiology and Intensive Care Medicine, Wilhelminenhospital, Vienna, Austria Disclosures DISCLOSURE
Why Cardiac MRI? Presented by:
Why Cardiac MRI? Presented by: Lisa G. Carkner, MD, FACC 1 Disclosures I have no financial disclosures Objectives Review basic principles of Cardiac MRI. What patient characteristics do I need to consider
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
03/07/ Background. + High Risk Features Are Prevalent in Dialysis Patients
+ When Does Cardiovascular Disease Preclude Consideration of Renal Transplantation? Kul Aggarwal, MD, MRCP (UK), FACC Professor of Clinical Medicine Division of Cardiology University of Missouri & Chief,
Course Schedule: Pharmacotherapy II Spring 2011 Revised 12/6/2010
Course Schedule: Pharmacotherapy II Spring 2011 Revised 12/6/2010 All lectures will be held from 9:05-11:00 am Monday and Wednesday, as well as 10:10-11:00 am Friday in room MoosT 1-450 and LS 163 (),
Antithrombotic therapy in the ACS patient with atrial fibrillation
Antithrombotic therapy in the ACS patient with atrial fibrillation Kurt Huber, MD, FESC, FACC, FAHA 3 rd Medical Department Cardiology & Emergency Medicine Wilhelminenhospital Vienna, Austria Great Minds,
SCA ST- : recommandations européennes 2015 La durée de la bithérapie : à géométrie variable?
SCA ST- : recommandations européennes 2015 La durée de la bithérapie : à géométrie variable? tielle est 2 ré Totielle est interdite. Prof. Marco Roffi Hôpitaux Universitaires de Genève Research funding
Defibrillation Testing should be routinely performed at the time of ICD implantation. Jeff Healey MD, MSc, FHRS McMaster University
Defibrillation Testing should be routinely performed at the time of ICD implantation Jeff Healey MD, MSc, FHRS McMaster University Presenter Disclosure Information Jeff S. Healey, MD, MSc, McMaster University,
Oral anticoagulation/antiplatelet therapy in the secondary prevention of ACS patients the cost of reducing death!
Oral anticoagulation/antiplatelet therapy in the secondary prevention of ACS patients the cost of reducing death! Robert C. Welsh, MD, FRCPC Associate Professor of Medicine Director, Adult Cardiac Catheterization
North Wales Cardiac Network Guidelines on oral antiplatelet therapy in cardiovascular disease
Guidelines on oral antiplatelet therapy in cardiovascular disease This guidance should be considered as one part of the wider therapeutic management of patients. The indication for antiplatelet therapy
Controversies in Cardiac Pharmacology
Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?
ESC Heart & Brain Workshop
Supported by Bayer, Bristol-Myers Squibb and Pfizer Alliance, Boehringer Ingelheim, Daiichi Sankyo Europe GmbH and Medtronic in the form of educational grants. The scientific programme has not been influenced
Susan P. D Anna MSN, APRN BC February 14, 2019
Is there Equal Opportunity in Heart Failure?? Susan P. D Anna MSN, APRN BC February 14, 2019 Disclosures: I have no financial disclosures. I am not an expert on this topic, but see a lot of women with
CABG Surgery following STEMI
CABG Surgery following STEMI Susana Harrington, MS,APRN-NP Cardio-Thoracic Surgery Nebraska Methodist Hospital February 15, 2018 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction:
Organizational, or Other Financial Benefit None None None None None None. None None None None None None
Comprehensive Relationships With Industry and Other Entities AHA/ACC 2017 Update of ST-Elevation Myocardial Infarction and Non ST-Elevation Myocardial Infarction Measures Committee Jneid Hani, Chair Baylor
How to manage ACS patients with Comorbidities? Patients with Renal Failure
How to manage ACS patients with Comorbidities? Patients with Renal Failure François Schiele, MD, PhD Department of Cardiology, University Hospital Jean Minjoz, Besançon, France. Potential conflicts of
Women and Ischemic Heart Disease Lessons Learned
Women and Ischemic Heart Disease 2017- Lessons Learned Bina Ahmed MD Interventional Cardiology Dartmouth-Hitchcock Medical Center Assistant Professor of Medicine Geisel School of Medicine Lebanon, NH ba@hitchcock.org
Acute Coronary Syndrome. Sonny Achtchi, DO
Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification
LVHN Cardiac Diagnostic Testing PCP/PCP Office Testing Cheat Sheet. September 2017
LVHN Cardiac Diagnostic Testing PCP/PCP Office Testing Cheat Sheet September 2017 1. ECHOCARDIOGRAM A (transthoracic) echocardiogram (2D Echo) is a 2-dimensional graphic of the heart s movement, valves
4:30 p.m. Jack Vogel Memorial Lecture Evolution and Revolution in the Treatment of Valvular Heart Disease Dr. Mack
AGENDA Friday, January 12 4:30 p.m. Registration at Westin Snowmass Conference Center 6:30 p.m. Saturday, January 13 3:30 p.m. Registration and Refreshment Break SESSION I Moderator: 4:00 p.m. Welcome
Gestione della DAPT post-pci in chirurgia cardiaca e non cardiaca
Gestione della DAPT post-pci in chirurgia cardiaca e non cardiaca Francesco Saia Polo Cardio-Toraco-Vascolare Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola Malpighi Bologna DISCLOSURE
Program Schedule Cardiology Update: The Heart of the Matter 2018
Program Schedule Cardiology Update: The Heart of the Matter 2018 Thursday, August 2, 2018 12:00 p.m. Registration and Exhibits 1:50 p.m. Welcome Announcements SESSION 1 2:00 p.m. Syncope in Patients with
Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh
Stress ECG is still Viable in 2016 Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh Stress ECG Do we still need stress ECG with all the advances we have in the CV field?
Advanced Heart Failure and Transplant Cardiology
Advanced Heart Failure and Transplant Cardiology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills
Chapter 8: Cardiovascular Disease in Patients with ESRD
Chapter 8: Cardiovascular Disease in Patients with ESRD Cardiovascular disease (CVD) is common in adult end-stage renal disease (ESRD) patients, with coronary artery disease (CAD) and heart failure (HF)
Heart Failure in Women
Heart Failure in Women Disclosure Professor Sindone has received honoraria, speaker fees, consultancy fees, is a member of advisory boards or has appeared on expert panels for: Professor Andrew Sindone
Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy
Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy Learning Objectives Learn to recognize the high risk patient Discuss effective management of a high risk NSTEMI patient Review CCS
CARDIOLOGY GRAND ROUNDS
CARDIOLOGY GRAND ROUNDS Presentation: Date: Location: Speaker: ACC 2015 PREVIEW Monday, March 9, 2015, 7:00 8:00 AM ANW Education Building, Watson Room Elevated Troponin in Patients Presenting to the Emergency
Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD
Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference
CuRe PreClerkship Presentation. CARDIOVASCULAR COURSE Anita Soni MD FRCP (C) January 23, 2014
CuRe PreClerkship Presentation CARDIOVASCULAR COURSE Anita Soni MD FRCP (C) January 23, 2014 DRAFT 5 Nov 1, 2013 Y1 M1 Y2 M2 CuRe Preclerkship M0, 1/2: Human Biology, Health and Human Disease Biology and
TYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016
TYPE II MI KC ACDIS LOCAL CHAPTER March 8, 2016 TYPE 2 MI DEFINITION: Acute coronary syndrome (ACS) encompasses a continuum of myocardial ischemia and infarction, which can make the diagnostic and coding
WHICH ANTITHROMBOTIC REGIMEN? Action Study Group Institut de Cardiologie - Pitié-Salpêtrière Hospital Paris, France.
TAVI WITH ATRIAL FIBRILLATION: WHICH ANTITHROMBOTIC REGIMEN? G. MONTALESCOT (PARIS, FR) Action Study Group Institut de Cardiologie - Pitié-Salpêtrière Hospital Paris, France www.action-cœur.org Dr. Montalescot
Ultrasound 10/1/2014. Basic Echocardiography for the Internist. Mechanical (sector) transducer Piezoelectric crystal moved through a sector sweep
Ultrasound Basic Echocardiography for the Internist Carol Gruver, MD, FACC UT Erlanger Cardiology Mechanical wave of compression and rarefaction Requires a medium for transmission Ultrasound frequency
Department of Medicine III, Martin Luther-University Halle, Germany b. Unità Operativa di Cardiologia, Ospedale Maggiore, Bologna, Italy c
Comparison of CHADS 2 -Score with CHA 2 DS 2 VASc-Score in a prospective multicenter registry on patients with atrial fibrillation undergoing coronary artery stenting -First results from the AFCAS-trial-
Competency Portfolio for the Diploma in Adult Interventional Cardiology
Competency Portfolio for the Diploma in Adult Interventional Cardiology For Candidates to Complete 2013 VERSION 2.1 This portfolio applies to those who begin training on or after July 1 st, 2013. DEFINITION
University of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CCU Rotation Goals and Objectives Goals
Goals Learn to coordinate a variety of data from multiple cardiovascular sub-disciplines, e.g. catheterization laboratory, hemodynamic study, non-invasive imaging, nuclear, electrophysiologic, and in combination
Quality Measures MIPS CV Specific
Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from
Chapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD The prevalence of cardiovascular disease is 68.8% among patients aged 66 and older who have CKD, compared to 34.1% among those who do not have CKD